Elekta (OTCMKTS:EKTAY) Trading Down 4.7% – What’s Next?

by · The Cerbat Gem

Elekta AB (OTCMKTS:EKTAY – Get Free Report)’s stock price traded down 4.7% on Tuesday . The stock traded as low as $5.7150 and last traded at $5.7150. 716 shares changed hands during trading, a decline of 93% from the average session volume of 10,883 shares. The stock had previously closed at $5.9950.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on EKTAY. Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 16th. UBS Group assumed coverage on shares of Elekta in a report on Wednesday, September 3rd. They issued a “sell” rating for the company. Three research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Elekta currently has an average rating of “Reduce”.

Read Our Latest Analysis on Elekta

Elekta Price Performance

The company has a market capitalization of $2.12 billion, a P/E ratio of 82.01 and a beta of 1.04. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.05 and a quick ratio of 0.82. The firm’s 50-day moving average is $5.08 and its 200-day moving average is $5.05.

Elekta (OTCMKTS:EKTAY – Get Free Report) last issued its quarterly earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $427.85 million for the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.06%. Analysts predict that Elekta AB will post 0.36 EPS for the current fiscal year.

Elekta Company Profile

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Featured Articles